English | Español

Biospace
+ Pharmaceuticals
Patient Daily | Jan 19, 2026

Rampart Bioscience shuts down less than two years after high-profile launch
+ Pharmaceuticals
Patient Daily | Jan 19, 2026

FDA introduces flexible rules for cell and gene therapy manufacturing
+ Pharmaceuticals
Patient Daily | Jan 19, 2026

Moderna reports progress on cost-cutting but faces questions over break-even timeline
+ Pharmaceuticals
Patient Daily | Jan 19, 2026

Aurora Therapeutics launches with $16M seed round aiming at scalable personalized gene therapy
+ Pharmaceuticals
Patient Daily | Jan 19, 2026

FDA removes special risk program for CAR T therapies amid calls for better side effect management
+ Pharmaceuticals
Patient Daily | Jan 19, 2026

Early-stage biotech funding drops as investors shift focus to late-stage assets
+ Pharmaceuticals
Patient Daily | Jan 19, 2026

Veradermics and Eikon Therapeutics announce plans for initial public offerings
+ Pharmaceuticals
Patient Daily | Jan 19, 2026

Novartis enters global Alzheimer’s partnership with SciNeuro Pharmaceuticals

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation